Superworth

Beta Bionics profit margin BBNX

Gross, operating and net profit as a share of revenue over the last twelve months, from 2024.

Net margin, 12 months
−61.3%
Operating margin, 12 months
−69.8%
Net margin on a year earlier
+32.7 pts
Peer median
6.5%

Over the twelve months to Jun 30, 2026, Beta Bionics kept −61.3% of its revenue as net profit, with an operating margin of −69.8% and a gross margin of 58.3%.

The median for 10 medical instruments and supplies stocks of a similar size is 6.5%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−73.0%−71.5%55.4%
FY2024−84.1%−69.5%55.1%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−61.3%+32.7 pts−69.8%
Q1 FY26−60.3%n/a−70.1%
Q4 FY25−73.0%+11.1 pts−71.5%
Q3 FY25−87.9%n/a−77.4%
Q2 FY25−94.0%n/a−80.1%
Q1 FY25n/an/a−78.0%
Q4 FY24−84.1%n/a−69.5%
Q3 FY24n/an/an/a
Q2 FY24n/an/an/a
Q1 FY24n/an/an/a

Against its peers

Companies in Medical - Instruments & Supplies nearest Beta Bionics' size, closest first, today.

CompanyProfit margin
BBNXBeta Bionics−61.3%
MOVMovado6.0%
IRMDIradimed26.7%
STAAStaar Surgical1.1%
BVSBioventus9.4%
CDRECadre5.3%
MDXGMimedx1.8%
TCMDTactile Systems Technology7.1%
EYENational Vision2.5%
LMATLemaitre Vascular25.0%
EMBCEmbecta8.6%
Peer median6.5%

Where Beta Bionics ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Beta Bionics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.